1. |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 394-424.
|
2. |
中华医学会, 中华医学会肿瘤学分会, 中华医学会杂志社. 中华医学会肺癌临床诊疗指南(2019版). 中华肿瘤杂志, 2020, 42(4): 257-287.
|
3. |
Khakwani A, Harden S, Beckett P, et al. Post-treatment survival difference between lobectomy and stereotactic ablative radiotherapy in stage Ⅰ non-small cell lung cancer in England. Thorax, 2020, 75(3): 237-243.
|
4. |
Bedetti B, Bertolaccini L, Rocco R, et al. Segmentectomy versus lobectomy for stage Ⅰ non-small cell lung cancer: A systematic review and meta-analysis. J Thorac Dis, 2017, 9(6): 1615-1623.
|
5. |
Cao J, Yuan P, Wang Y, et al. Survival rates after lobectomy, segmentectomy, and wedge resection for non-small cell lung cancer. Ann Thorac Surg, 2018, 105(5): 1483-1491.
|
6. |
Moon MH, Moon YK, Moon SW. Segmentectomy versus lobectomy in early non-small cell lung cancer of 2 cm or less in size: A population-based study. Respirology, 2018, 23(7): 695-703.
|
7. |
Shao C, Zheng C, Yan W, et al. Evaluation of efficacy and safety of minimally invasive segmentectomy in the treatment of lung cancer. Oncol Lett, 2018, 15(6): 9516-9522.
|
8. |
Gu Z, Wang H, Mao T, et al. Pulmonary function changes after different extent of pulmonary resection under video-assisted thoracic surgery. J Thorac Dis, 2018, 10(4): 2331-2337.
|
9. |
Sagawa M, Oizumi H, Suzuki H, et al. A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacity. Eur J Cardiothorac Surg, 2018, 53(4): 849-856.
|
10. |
Jiao P, Sun Y, Tian W, et al. Simple method for distinguishing the intersegmental plane in thoracoscopic lung segmentectomy. Thorac Cancer, 2020, 11(6): 1758-1760.
|
11. |
高永山, 薛占霞, 董跃华, 等. 单操作孔胸腔镜治疗早期周围型非小细胞肺癌. 中国胸心血管外科临床杂志, 2016, 23(12): 1132-1135.
|
12. |
卢开进, 贾卫光, 申江峰. 单孔胸腔镜与两孔胸腔镜手术治疗肺癌的效果及创伤程度评估. 中国内镜杂志, 2018, 24(1): 60-65.
|
13. |
Ng CS, Lau KK. Surgical trauma and immune functional changes following major lung resection. Indian J Surg, 2015, 77(1): 49-54.
|
14. |
刘让, 解明然, 柯立, 等. 微创肺段切除术与肺叶切除术治疗早期NSCLC近期结果分析. 安徽医科大学学报, 2018, 53(5): 769-773.
|
15. |
刘懿, 赵洪林, 刘京豪, 等. 胸腔镜早期周围型肺癌根治术对患者术后炎性反应状态的影响. 中国肺癌杂志, 2014, 17(10): 730-733.
|
16. |
张艳娇, 高禹舜. 肺癌胸腔镜肺叶切除、胸腔镜肺段切除与开胸肺叶切除术后对肺功能影响的研究. 中国肺癌杂志, 2016, 19(10): 700-704.
|
17. |
Kinoshita T, Goto T. Molecular mechanisms of pulmonary fibrogenesis and its progression to lung cancer: A review. Int J Mol Sci, 2019, 20(6): 1461.
|
18. |
Nojiri T, Hamasaki T, Inoue M, et al. Long-term impact of postoperative complications on cancer recurrence following lung cancer surgery. Ann Surg Oncol, 2017, 24(4): 1135-1142.
|
19. |
Li YD, Lamano JB, Lamano JB, et al. Tumor-induced peripheral immunosuppression promotes brain metastasis in patients with non-small cell lung cancer. Cancer Immunol Immunother, 2019, 68(9): 1501-1513.
|
20. |
Ivanova OK, Sharapova TN, Romanova EA, et al. CD3+ CD8+ NKG2D+ T lymphocytes induce apoptosis and necroptosis in hla-negative cells via fasl-fas interaction. J Cell Biochem, 2017, 118(10): 3359-3366.
|
21. |
Antonia SJ, Villegas A, Daniel D, et al. Durvalumab after chemoradiotherapy in stage Ⅱ non-small-cell lung cancer. N Engl J Med, 2017, 377(20): 1919-1929.
|
22. |
Forde PM, Chaft JE, Smith KN, et al. Neoadjuvant PD-1 blockade in resectable lung cancer. N Engl J Med, 2018, 378(21): 1976-1986.
|
23. |
吴占波, 赵宁, 申学杰, 等. 非小细胞肺癌原发灶PET/CT SUVmax与免疫细胞亚群浸润的相关性及其临床意义. 中国肿瘤临床, 2017, 44(3): 112-117.
|